Abiopharma

News list

Ryan Owen 🟢 acquired 1.3K shares (1 derivative) of LINCOLN NATIONAL CORP (LNC) Transaction Date: Jun 30, 2026 | Filing ID: 008112

Full text

News bot July 2, 2026, 11:37 a.m.
🔍 Ryan Owen (Executive)

Company: LINCOLN NATIONAL CORP (LNC)

Report Date: 2026-06-30
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,273
Detailed Transactions and Holdings:
- Acquired 1,273 shares of Phantom Stock Unit (Derivative)
  Date: 2026-06-30 | Code: A | equity_swap_involved: false | shares_owned_after: 24,673.17 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3
Footnotes:
- F1: Each Phantom Stock Unit is the equivalent of one share of LNC Common Stock.
- F2: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the LNC Deferred Compensation Plan for Non-employee Directors (the "Directors' DCP") in the LNC Stock Fund investment account, which are payable solely in shares of LNC Common Stock at resignation or retirement. The reporting person may transfer his/her phantom stock unit holdings into an alternative investment account in the Director's DCP at any time.
- F3: Includes 277.26 shares acquired through dividend reinvestment since the reporting person's last report.